ViiV Healthcare begins study on implementation of once-monthly injectable HIV treatment

This article was originally published here

ViiV Healthcare said that its team will work with clinical staff at different sites across the US to conduct one-year CUSTOMIZE trial (cabotegravir plus rilpivirine in the US

The post ViiV Healthcare begins study on implementation of once-monthly injectable HIV treatment appeared first on Pharmaceutical Business review.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply